Cogent Biosciences, Inc.COGTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+30.8%
5Y CAGR+38.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+30.8%/yr
vs +34.1%/yr prior
5Y CAGR
+38.8%/yr
Recent deceleration
Acceleration
-3.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $331.03M | +20.0% |
| 2024 | $275.94M | +32.6% |
| 2023 | $208.13M | +40.8% |
| 2022 | $147.84M | +95.7% |
| 2021 | $75.55M | +17.4% |
| 2020 | $64.33M | +17.7% |
| 2019 | $54.68M | +19.5% |
| 2018 | $45.74M | +32.5% |
| 2017 | $34.51M | +35.7% |
| 2016 | $25.43M | - |